Disease Overview：Hypoactive Sexual Desire（HSDD）
Hypoactive sexual desire disorder (HSDD) in males—commonly referred to as low libido or diminished sexual drive—is a clinically recognized condition characterized by a persistent or recurrent deficiency in sexual thoughts, fantasies, and desire for sexual activity, causing personal distress. It differs from erectile dysfunction (ED) in that it primarily involves motivational and neuroendocrine components rather than mechanical or vascular impairment. Etiologies are multifactorial: hormonal imbalances (e.g., low testosterone, elevated prolactin), psychological factors (depression, anxiety, relationship stress), chronic conditions (diabetes, metabolic syndrome), medications (SSRIs, antihypertensives), and lifestyle contributors (sleep deprivation, obesity, substance use). Accurate diagnosis requires comprehensive evaluation—including serum testosterone, LH, FSH, prolactin, thyroid function, and validated psychometric tools—followed by individualized management integrating endocrinological, behavioral, and pharmacological strategies.
China offers distinct advantages for international patients seeking evidence-based HSDD care. Leading urology and andrology centers—such as Peking University First Hospital and Shanghai Renji Hospital—employ multidisciplinary teams with deep expertise in male sexual medicine, utilizing advanced diagnostics (mass spectrometry-based hormone assays, functional MRI for neural pathway assessment) and FDA- and NMPA-approved therapies (testosterone replacement, bupropion off-label protocols, cognitive-behavioral therapy integration). Clinical outcomes reflect high patient satisfaction rates, particularly in cases involving comorbid metabolic or psychiatric conditions. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising clinical rigor or regulatory compliance. As a dedicated medical tourism agency, we facilitate seamless access to these resources: verifying hospital accreditation, coordinating specialist consultations, providing itemized, transparent pricing in advance, arranging visa support and post-treatment follow-up—all tailored to international patients’ logistical and linguistic needs.
Hypoactive Sexual Desire: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Male Hypoactive Sexual Desire Disorder (HSDD)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Primary or secondary low libido with confirmed hormonal, psychological, or lifestyle contributors; no structural pathology.
- •Comprehensive Andrology Workup
- Serum testosterone (total & free), SHBG, LH, FSH, prolactin, TSH, fasting glucose & lipid panel: $115 - Optional: AMH, estradiol, cortisol (if adrenal suspicion): $42
- •Tiered Pharmacotherapy
- Transdermal gel (1% testosterone, 5g/day): $68/month - Intramuscular injection (cypionate/enanthate, 100–200 mg q2w): $45/month (drug only) + $18/injection admin fee - *Second-line (Adjunctive)*: - Bupropion SR (150 mg daily, off-label): $12/month - Cabergoline (for hyperprolactinemia): $22/month - *Psychological Support*: Cognitive behavioral therapy (CBT) session (45 min, andrology-integrated): $75/session (6-session minimum recommended)
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Documented hypogonadism unresponsive to TRT *and* confirmed pituitary/hypothalamic lesion on MRI; or severe penile vascular insufficiency contributing to desire loss via performance anxiety.
- •Pituitary MRI (3.0T, contrast-enhanced): $195
- •Transsphenoidal Surgery (for prolactinoma/corticotropinoma): $4,200–$6,800 (includes anesthesia, 3-day hospital stay, neurosurgery team fee)
- •Penile Doppler Ultrasound (with pharmacostimulation): $135
- •Low-Intensity Shockwave Therapy (Li-ESWT, 6 sessions): $1,150 (targeted for vascular-related desire loss refractory to lifestyle/TRT)
Special/Complex Condition Management
- •Late-Onset Hypogonadism with Metabolic Syndrome: Integrated care (endocrinology + andrology + nutritionist): $220 initial consult + $145/month multidisciplinary follow-up
- •Post-Prostatectomy HSDD (non-hormonal): Testosterone-avoidant protocol (tadalafil 5 mg daily + CBT + pelvic floor rehab): $185/month (drug + 2 rehab sessions)
- •Chronic Opioid-Induced Hypogonadism: Naltrexone-assisted TRT transition: $310/month (naltrexone + monitored TRT + monthly labs)
Quick Selection Guide
- •Age < 45, Low Budget (<$500 total): Start with comprehensive lab work ($115) + lifestyle counseling ($0–$75) + bupropion if depression present ($12/month).
- •Age 45–65, Moderate Severity, T < 250 ng/dL: TRT gel ($68/month) + quarterly labs ($55) + 6 CBT sessions ($450 total).
- •Age > 65, Severe HSDD + MRI-confirmed microadenoma: Pituitary MRI ($195) → transsphenoidal surgery ($5,500 avg) → post-op endocrine follow-up ($145/visit).
- •Comorbid Diabetes/Obesity: Prioritize metabolic optimization (nutritionist + GLP-1 agonist if indicated) before TRT—cost: $220 initial + $145/month integrated care.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Hypoactive Sexual Desire Medical Vacation Packages
Curated transparent all-inclusive packages combining Hypoactive Sexual Desire treatment with China top medical destinations:
